Zoetis (ZTS) Retained Earnings (2012 - 2026)
Zoetis (ZTS) posted quarterly Retained Earnings of $1.1 billion for Q1 2026, up 208.65% year-over-year from $358.0 million in Q1 2025, and up 237.44% quarter-over-quarter from -$804.0 million in Q4 2025.
Zoetis (ZTS) Retained Earnings (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Retained Earnings for 15 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 208.65% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 208.65% YoY), while the FY2025 annual figure was -$804.0 million, down 106.72% from the prior year.
- Retained Earnings rose to $1.1 billion in Q1 2026 per ZTS's latest filing, from -$804.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at $12.0 billion in Q4 2024 and bottomed at -$1.0 billion in Q1 2025.
- Historically, Retained Earnings has averaged $1.7 billion across 5 years, with a median of -$804.0 million in 2025.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 5452.94% — and 2024, when it soared 1550.37%.
- Zoetis' Retained Earnings stood at -$944.0 million in 2022, then climbed by 11.12% to -$839.0 million in 2023, then surged by 1526.46% to $12.0 billion in 2024, then tumbled by 106.72% to -$804.0 million in 2025, then soared by 237.44% to $1.1 billion in 2026.
- Business Quant data shows ZTS's Retained Earnings at $1.1 billion in Q1 2026, -$804.0 million in Q4 2025, and $1.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | -800.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.65 Bn |
| Mar 31, 2026 | 1.11 Bn |
| Dec 31, 2025 | -804.00 Mn |
| Sep 30, 2025 | 1.22 Bn |
| Jun 30, 2025 | -877.00 Mn |
| Mar 31, 2025 | -1.02 Bn |
| Dec 31, 2024 | 11.97 Bn |
| Sep 30, 2024 | 11.81 Bn |
| Jun 30, 2024 | -845.00 Mn |
| Mar 31, 2024 | 1.13 Bn |
| Dec 31, 2023 | -839.00 Mn |
| Sep 30, 2023 | -814.00 Mn |
| Jun 30, 2023 | -895.00 Mn |
| Mar 31, 2023 | 1.08 Bn |
| Dec 31, 2022 | -944.00 Mn |
| Sep 30, 2022 | -809.00 Mn |
| Jun 30, 2022 | 1.06 Bn |
| Mar 31, 2022 | 7.63 Bn |
| Dec 31, 2021 | -17.00 Mn |
| Sep 30, 2021 | -667.00 Mn |